Prostate cancer: Abiraterone treatment improves overall survival in patients with mCRPC.

Sidaway, Peter

Prostate cancer: Abiraterone treatment improves overall survival in patients with mCRPC. [electronic resource] - Nature reviews. Urology Mar 2015 - 120 p. digital

Publication Type: Journal Article; Comment

1759-4820

10.1038/nrurol.2015.14 doi


Androstenols
Humans
Male
Prostatic Neoplasms, Castration-Resistant